Skip to main content
Premium Trial:

Request an Annual Quote

Gianfranco de Feo, William Beltz, Joseph DeRisi, Vamsi Mootha, Steven Burrill, Masahide Habu, and Mark Stevenson


Guava Technologies has hired Gianfranco de Feo as director of customer support and service, the Hayward, Calif.-based company said yesterday.

De Feo joins Guava from Affymetrix, where he served as associate director of genomics collaborations. He has also served as a field application specialist at Perkin Elmer/Applied Biosystems, Guava said. He received a PhD in neuronal and embryonic development from the University of California, Los Angeles.

MFIC said yesterday that its microfluidics division has named William Beltz as industry marketing manager. Beltz will be responsible for the company’s Microfluidizer processors, primarily in the biotechnology and pharmaceutical sectors, MFIC said, and will also lead the launch of the company’s new high-pressure Multiple Stream Mixer Reactor for the continuous creation of nanoparticles.

Beltz has held product management and marketing positions at Applied Biosystems, Schleicher & Schuell, DuPont Biotechnology Systems, and NEN, MFIC said. He also led his own firm, Biotechnology Associates, a biotechnology consulting service.

Joseph DeRisi and Vamsi Mootha are among 23 new MacArthur fellows named by the MacArthur Foundation last week. Each fellow will receive $500,000 over the next five years. DeRisi, who has been developing microarrays, is an assistant professor of biochemistry and biophysics at the University of California, San Francisco. He was cited for “developing the means to measure thousands of genes simultaneously in an effort to decode the mysteries of cellular function.” Mootha is an assistant professor of systems biology at Harvard Medical School. He was honored for “tapping into the wellspring of new data from molecular biology, genetics, and protein chemistry to identify the cause of, and possible treatment for, metabolic disease such as diabetes.”

Steven Burrill, CEO of life sciences merchant bank Burrill & Company, has been named chairman of the newly formed San Francisco Mayor’s Biotechnology Advisory Council (MayBAC), the organization said yesterday.

Burrill has been working for San Francsico mayor Gavin Newsom to create MayBAC, the goal of which is to “foster the growth of the biotech industry in the city and county of San Francisco,” MayBAC said.

Applied Biosystems has appointed Masahide Habu as president of ABI Japan. Habu will manage approximately 280 employees as the overseer of ABI’s Japanese operations, the company said.

Prior to becoming president of ABI’s Japanese division, Habu was director of sales and marketing at ABI for one year. Before that, he was general manager of Kodak Professional’s Japan region, and vice president of health sciences for the Asia and Pacific Region at Kodak.

Mark Stevenson, the former president and general manager of ABI Japan, has been appointed to division president of applied markets at ABI.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.